Your browser doesn't support javascript.
loading
Phylogenetic lineages of tuberculosis isolates and their association with patient demographics in Tanzania.
Mutayoba, Beatrice Kemilembe; Heinrich, Norbert; Joloba, Moses L; Lyamuya, Eligius; Kilale, Andrew Martin; Range, Nyagosya Segere; Ngowi, Bernard James; Ntinginya, Nyanda Elias; Mfaume, Saidi Mwinjuma; Wilfred, Amani; Doulla, Basra; Lyimo, Johnson; Kisonga, Riziki; Kingalu, Amri; Kabahita, Jupiter Marina; Guido, Ocung; Kabugo, Joel; Adam, Isa; Luutu, Moses; Namaganda, Maria Magdalene; Namutebi, Joanitah; Kasule, George William; Nakato, Hasfah; Byabajungu, Henry; Lutaaya, Pius; Musisi, Kenneth; Oola, Denis; Mboowa, Gerald; Pletschette, Michel.
Afiliação
  • Mutayoba BK; Department of Preventive Services, Ministry of Health, Dodoma, Tanzania. beatricemutayoba@yahoo.com.
  • Michael Hoelscher; Department of Infectious Diseases and Tropical Medicine, Medical Center of the, University of Munich, Munich, Germany. beatricemutayoba@yahoo.com.
  • Heinrich N; Department of Infectious Diseases and Tropical Medicine, Medical Center of the, University of Munich, Munich, Germany.
  • Joloba ML; Department of Infectious Diseases and Tropical Medicine, Medical Center of the, University of Munich, Munich, Germany.
  • Lyamuya E; National Tuberculosis Reference Laboratory/Supranational Reference Laboratory, Luzira, Uganda.
  • Kilale AM; Department of Immunology and Molecular Biology, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Range NS; Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania.
  • Ngowi BJ; Muhimbili Research Centre, National Institute for Medical Research (NIMR), Dar es Salaam, Tanzania.
  • Ntinginya NE; Muhimbili Research Centre, National Institute for Medical Research (NIMR), Dar es Salaam, Tanzania.
  • Mfaume SM; Muhimbili Research Centre, National Institute for Medical Research (NIMR), Dar es Salaam, Tanzania.
  • Wilfred A; University of Dar Es Salaam, Mbeya College of Health and Allied Sciences, Mbeya, Tanzania.
  • Doulla B; Mbeya Medical Research Centre, NIMR, Mbeya, Tanzania.
  • Lyimo J; Muhimbili Research Centre, National Institute for Medical Research (NIMR), Dar es Salaam, Tanzania.
  • Kisonga R; Muhimbili Research Centre, National Institute for Medical Research (NIMR), Dar es Salaam, Tanzania.
  • Kingalu A; Central Tuberculosis Reference Laboratory, Ministry of Health, National TB and Leprosy Programme, Dar es Salaam, Tanzania.
  • Kabahita JM; Department of Preventive Services, Ministry of Health, National Tuberculosis and Leprosy Programme, Dodoma, Tanzania.
  • Guido O; Department of Preventive Services, Ministry of Health, National Tuberculosis and Leprosy Programme, Dodoma, Tanzania.
  • Kabugo J; Central Tuberculosis Reference Laboratory, Ministry of Health, National TB and Leprosy Programme, Dar es Salaam, Tanzania.
  • Adam I; National Tuberculosis Reference Laboratory/Supranational Reference Laboratory, Luzira, Uganda.
  • Luutu M; National Tuberculosis Reference Laboratory/Supranational Reference Laboratory, Luzira, Uganda.
  • Namaganda MM; National Tuberculosis Reference Laboratory/Supranational Reference Laboratory, Luzira, Uganda.
  • Namutebi J; National Tuberculosis Reference Laboratory/Supranational Reference Laboratory, Luzira, Uganda.
  • Kasule GW; Department of Immunology and Molecular Biology, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Nakato H; Department of Immunology and Molecular Biology, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Byabajungu H; National Tuberculosis Reference Laboratory/Supranational Reference Laboratory, Luzira, Uganda.
  • Lutaaya P; National Tuberculosis Reference Laboratory/Supranational Reference Laboratory, Luzira, Uganda.
  • Musisi K; National Tuberculosis Reference Laboratory/Supranational Reference Laboratory, Luzira, Uganda.
  • Oola D; National Tuberculosis Reference Laboratory/Supranational Reference Laboratory, Luzira, Uganda.
  • Mboowa G; National Tuberculosis Reference Laboratory/Supranational Reference Laboratory, Luzira, Uganda.
  • Pletschette M; National Tuberculosis Reference Laboratory/Supranational Reference Laboratory, Luzira, Uganda.
BMC Genomics ; 23(1): 561, 2022 Aug 05.
Article em En | MEDLINE | ID: mdl-35931954
ABSTRACT

BACKGROUND:

Mycobacterium tuberculosis presents several lineages each with distinct characteristics of evolutionary status, transmissibility, drug resistance, host interaction, latency, and vaccine efficacy. Whole genome sequencing (WGS) has emerged as a new diagnostic tool to reliably inform the occurrence of phylogenetic lineages of Mycobacterium tuberculosis and examine their relationship with patient demographic characteristics and multidrug-resistance development.

METHODS:

191 Mycobacterium tuberculosis isolates obtained from a 2017/2018 Tanzanian drug resistance survey were sequenced on the Illumina Miseq platform at Supranational Tuberculosis Reference Laboratory in Uganda. Obtained fast-q files were imported into tools for resistance profiling and lineage inference (Kvarq v0.12.2, Mykrobe v0.8.1 and TBprofiler v3.0.5). Additionally for phylogenetic tree construction, RaxML-NG v1.0.3(25) was used to generate a maximum likelihood phylogeny with 800 bootstrap replicates. The resulting trees were plotted, annotated and visualized using ggtree v2.0.4

RESULTS:

Most [172(90.0%)] of the isolates were from newly treated Pulmonary TB patients. Coinfection with HIV was observed in 33(17.3%) TB patients. Of the 191 isolates, 22(11.5%) were resistant to one or more commonly used first line anti-TB drugs (FLD), 9(4.7%) isolates were MDR-TB while 3(1.6%) were resistant to all the drugs. Of the 24 isolates with any resistance conferring mutations, 13(54.2%) and 10(41.6%) had mutations in genes associated with resistance to INH and RIF respectively. The findings also show four major lineages i.e. Lineage 3[81 (42.4%)], followed by Lineage 4 [74 (38.7%)], the Lineage 1 [23 (12.0%)] and Lineages 2 [13 (6.8%)] circulaing in Tanzania.

CONCLUSION:

The findings in this study show that Lineage 3 is the most prevalent lineage in Tanzania whereas drug resistant mutations were more frequent among isolates that belonged to Lineage 4.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Resistente a Múltiplos Medicamentos / Mycobacterium tuberculosis Tipo de estudo: Risk_factors_studies Limite: Humans País/Região como assunto: Africa Idioma: En Revista: BMC Genomics Assunto da revista: GENETICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Tanzânia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Resistente a Múltiplos Medicamentos / Mycobacterium tuberculosis Tipo de estudo: Risk_factors_studies Limite: Humans País/Região como assunto: Africa Idioma: En Revista: BMC Genomics Assunto da revista: GENETICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Tanzânia